NKILA and neoplasm: Previous studies1,2,3 that investigated the interaction between long noncoding RNAs (lncRNAs) biology and immunomicroenvironment components demonstrated that high nuclear factor (NF)-κB–interacting lncRNA (NKILA [Ensembl ENSG00000278709]) in tumor-specific cytotoxic T lymphocytes (CTLs) or in tumor cells and high hypoxia-inducible factor 1α–stabilizing lncRNA in tumor-associated macrophages indicated a poor prognosis.